ZalogujUżytkownikHasło
Zaloguj mnie automatycznie przy każdej wizycie    
Rejestracja
Rejestracja
Zaloguj się, by sprawdzić wiadomości
Zaloguj się, by sprawdzić wiadomości
Forum Integrum Consulting - Strona Główna » Pozwolenia zintegrowane

Napisz nowy temat   Odpowiedz do tematu
Evaluation of sHLA-G levels in serum of patients with prosta
Zobacz poprzedni temat :: Zobacz następny temat  
Autor Wiadomość
smarty



Dołączył: 10 Paź 2017
Posty: 25

PostWysłany: Wto Paź 10, 2017 06:19    Temat postu: Evaluation of sHLA-G levels in serum of patients with prosta Odpowiedz z cytatem

Evaluation of sHLA-G levels in serum of patients with prostate cancer identify as a potential of tumor marker.

Prostate cancer Prostatitis Treatment is the most common
Prostatitiscancer type in men and is the second
cause of death, Chronic Prostatitis due to cancer,
in patients over 50 Chronic Pelvic Pain Syndrome ,
after lung cancer BPH Treatment . Prostate specific antigen
(PSA) is a widely used Blood In Semen tumor marker for prostate cancer.
Recently Blood in Urine,
PSA is discovered in non-prostatic Burning While Urinating cancer
tissues in men and women Difficulty Urinatingraising doubts about
its specificity for prostatic tissues Pain While Urinating.
PSA exists in low serum level in healthy Frequent Urination men and in higher levels
in many prostate disorders, including prostatitis and prostate cancer Painful Ejaculation.
Thus, a supplementary tumor marker is needed to Prostatitis Antibiotics accurately
diagnose the cancer and to observe the patient after treatment Treatment of Prostatitis.
Recently, soluble human leukocyte antigen-G (sHLA-G) Chronic Prostatitis Symptomshas been introduced as a new
tumor marker for different cancer types Prostatic Hypertrophy,
including colorectal, breast, lung, and ovary.Nonbacterial Prostatitis The
present descriptive-experimental study was carried out including patients Causes of Prostatitis
with malignant prostate tumor,Amoxicillin Prostatitis patients with benign
prostate tumor, and a group of health men as the control group Treatment for BPH,
as judged by an oncologist as well as a pathologist. After sterile blood sampling,Doxycycline Prostatitis sHLA-G was measured by
enzyme-linked immunosorbent assay in each group. ProstatectomyThe data was then
analyzed using one-way ANOVA. P≤0.05 was BPH Symptoms considered as statistically significant.
The results showed that the mean of sHLA-G level was high in patients. Also, it was found that there was a significant difference
in sHLA serum level between the three groups. Prostatitis Cure The data revealed that sHLA-G can be a novel supplementary tumor marker in addition to
PSA to diagnose prostate cancer.

Prostatitis Diet
Powrót do góry
Ogląda profil użytkownika Wyślij prywatną wiadomość Odwiedź stronę autora
Wyświetl posty z ostatnich:   
Napisz nowy temat   Odpowiedz do tematu    Forum Integrum Consulting - Strona Główna » Pozwolenia zintegrowane Wszystkie czasy w strefie CET (Europa)
Strona 1 z 1

 
Skocz do:  
Nie możesz pisać nowych tematów
Nie możesz odpowiadać w tematach
Nie możesz zmieniać swoich postów
Nie możesz usuwać swoich postów
Nie możesz głosować w ankietach

Powered by phpBB © 2001, 2002 phpBB Group
iCGstation v1.0 Template By Ray © 2003, 2004 iOptional